Mediar commences dosing in Phase II trial of MTX-463 for IPF
Mediar Therapeutics has dosed the first subject in the Phase II WISPer trial of its investigational therapy, MTX-463, for idiopathic…
Respiratory
-
-
Sanofi and Regeneron report results from two Phase III trials of COPD treatment
Sanofi and Regeneron have reported that the Phase III AERIFY-1 trial of the fully human monoclonal antibody itepekimab in former…
-
Rein Therapeutics doses first subject in Phase II trial to treat IPF
US-based biopharmaceutical company Rein Therapeutics has dosed the first subject in a Phase II trial of LTI-03, its lead asset…
-
Apnimed to seek approval for sleep apnoea pill after Phase III success
Apnimed’s oral sleep apnoea therapy AD109 has met the primary endpoint in a Phase III trial, with hopes to file…
-
Rejuvenate Biomed doses first subject in COPD-related muscle weakness trial
Rejuvenate Biomed has dosed the first subject in the randomised Phase II trial to assess its lead compound, RJx-01, for…
-
Nuance seeks China approval for Ohtuvayre following Phase III trial success
Nuance Pharma’s Ohtuvayre (ensifentrine) has met the primary endpoint in a Phase III chronic obstructive pulmonary disease (COPD) study in…
-
First subject dosed in Revolution Medicines’ Phase III NSCLC treatment trial
Revolution Medicines has dosed the first subject in the Phase III RASolve 301 trial with the RAS (ON) multi-selective inhibitor,…
-
Connect Biopharma begins Phase II trial of drug for acute exacerbations in asthma
US-based biopharmaceutical company Connect Biopharma has started a Phase II trial to assess the efficacy and safety of rademikibart in…
-
OmRx Oncology begins Phase II trial of oral PD-L1 inhibitor for NSCLC
Clinical-stage biopharmaceutical venture OmRx Oncology (OmRx) has commenced a randomised Phase II clinical trial for its oral programmed death ligand…
-
Pliant cuts workforce by 45% following lung trial termination
Pliant Therapeutics will cut 45% of its workforce in a sweeping restructuring effort aimed at extending its cash runway, the…
